Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Glycemia affects glomerular filtration rate in people with type 2 diabetes.

Weil EJ, Kobes S, Jones LI, Hanson RL.

BMC Nephrol. 2019 Oct 29;20(1):397. doi: 10.1186/s12882-019-1584-7.

2.

Urine metabolites are associated with glomerular lesions in type 2 diabetes.

Saulnier PJ, Darshi M, Wheelock KM, Looker HC, Fufaa GD, Knowler WC, Weil EJ, Tanamas SK, Lemley KV, Saito R, Natarajan L, Nelson RG, Sharma K.

Metabolomics. 2018 Jun 8;14(6):84. doi: 10.1007/s11306-018-1380-6.

3.

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224-3231.

Weil EJ, Fufaa G, Jones LI, Lovato T, Lemley KV, Hanson RL, Knowler WC, Bennett PH, Yee B, Myers BD, Nelson RG.

Diabetes. 2018 Mar;67(3):532. doi: 10.2337/db18-er03a. Epub 2018 Jan 5. No abstract available.

4.

White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes.

Wheelock KM, Saulnier PJ, Tanamas SK, Vijayakumar P, Weil EJ, Looker HC, Hanson RL, Lemley KV, Yee B, Knowler WC, Hadjadj S, Najafian B, Mauer M, Nelson RG.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2145. doi: 10.1093/ndt/gfx303. No abstract available.

PMID:
29088394
5.

A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.

Nair V, Komorowsky CV, Weil EJ, Yee B, Hodgin J, Harder JL, Godfrey B, Ju W, Boustany-Kari CM, Schwarz M, Lemley KV, Nelson PJ, Nelson RG, Kretzler M.

Kidney Int. 2018 Feb;93(2):439-449. doi: 10.1016/j.kint.2017.08.013. Epub 2017 Oct 18.

6.

White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes.

Wheelock KM, Saulnier PJ, Tanamas SK, Vijayakumar P, Weil EJ, Looker HC, Hanson RL, Lemley KV, Yee B, Knowler WC, Hadjadj S, Najafian B, Mauer M, Nelson RG.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1001-1009. doi: 10.1093/ndt/gfx231.

PMID:
28992267
7.

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Wheelock KM, Cai J, Looker HC, Merchant ML, Nelson RG, Fufaa GD, Weil EJ, Feldman HI, Vasan RS, Kimmel PL, Rovin BH, Mauer M, Klein JB; CKD Biomarkers Consortium.

PLoS One. 2017 Jul 10;12(7):e0180964. doi: 10.1371/journal.pone.0180964. eCollection 2017.

8.

The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide.

Williams RC, Opelz G, Weil EJ, McGarvey CJ, Chakkera HA.

Transplant Direct. 2017 Apr 7;3(5):e152. doi: 10.1097/TXD.0000000000000664. eCollection 2017 May.

9.

Long-term Effect of Losartan on Kidney Disease in American Indians With Type 2 Diabetes: A Follow-up Analysis of a Randomized Clinical Trial.

Tanamas SK, Saulnier PJ, Fufaa GD, Wheelock KM, Weil EJ, Hanson RL, Knowler WC, Bennett PH, Nelson RG.

Diabetes Care. 2016 Nov;39(11):2004-2010. Epub 2016 Sep 9.

10.

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.

Saulnier PJ, Wheelock KM, Howell S, Weil EJ, Tanamas SK, Knowler WC, Lemley KV, Mauer M, Yee B, Nelson RG, Beisswenger PJ.

Diabetes. 2016 Dec;65(12):3744-3753. Epub 2016 Sep 8.

11.

The Authors' Reply.

Williams RC, Opelz G, Weil EJ, McGarvey CJ, Chakkera HA.

Transplantation. 2016 Sep;100(9):e52-3. doi: 10.1097/TP.0000000000001365. No abstract available.

12.

Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes.

Wheelock KM, Jaiswal M, Martin CL, Fufaa GD, Weil EJ, Lemley KV, Yee B, Feldman E, Brosius FC 3rd, Knowler WC, Nelson RG, Pop-Busui R.

J Diabetes Complications. 2016 Jul;30(5):873-9. doi: 10.1016/j.jdiacomp.2016.03.008. Epub 2016 Mar 11.

13.

The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors.

Williams RC, Opelz G, McGarvey CJ, Weil EJ, Chakkera HA.

Transplantation. 2016 May;100(5):1094-102. doi: 10.1097/TP.0000000000001115.

PMID:
26901078
14.

Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.

Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC 3rd, Yee B, Mauer M, Nelson RG.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):254-61. doi: 10.2215/CJN.05760515. Epub 2016 Jan 20.

15.

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.

Pavkov ME, Weil EJ, Fufaa GD, Nelson RG, Lemley KV, Knowler WC, Niewczas MA, Krolewski AS.

Kidney Int. 2016 Jan;89(1):226-34. doi: 10.1038/ki.2015.278. Epub 2016 Jan 4.

16.

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).

Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW, Burlock A, Chen YD, Cole SA, Comeau ME, Curtis JM, Divers J, Drechsler C, Duggirala R, Elston RC, Guo X, Huang H, Hoffmann MM, Howard BV, Ipp E, Kimmel PL, Klag MJ, Knowler WC, Kohn OF, Leak TS, Leehey DJ, Li M, Malhotra A, März W, Nair V, Nelson RG, Nicholas SB, O'Brien SJ, Pahl MV, Parekh RS, Pezzolesi MG, Rasooly RS, Rotimi CN, Rotter JI, Schelling JR, Seldin MF, Shah VO, Smiles AM, Smith MW, Taylor KD, Thameem F, Thornley-Brown DP, Truitt BJ, Wanner C, Weil EJ, Winkler CA, Zager PG, Igo RP Jr, Hanson RL, Langefeld CD; Family Investigation of Nephropathy and Diabetes (FIND).

PLoS Genet. 2015 Aug 25;11(8):e1005352. doi: 10.1371/journal.pgen.1005352. eCollection 2015 Aug.

17.

Role of Established Type 2 Diabetes-Susceptibility Genetic Variants in a High Prevalence American Indian Population.

Hanson RL, Rong R, Kobes S, Muller YL, Weil EJ, Curtis JM, Nelson RG, Baier LJ.

Diabetes. 2015 Jul;64(7):2646-57. doi: 10.2337/db14-1715. Epub 2015 Feb 9.

18.

A cis-eQTL in PFKFB2 is associated with diabetic nephropathy, adiposity and insulin secretion in American Indians.

Muller YL, Piaggi P, Hanson RL, Kobes S, Bhutta S, Abdussamad M, Leak-Johnson T, Kretzler M, Huang K, Weil EJ, Nelson RG, Knowler WC, Bogardus C, Baier LJ.

Hum Mol Genet. 2015 May 15;24(10):2985-96. doi: 10.1093/hmg/ddv040. Epub 2015 Feb 6.

19.

Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M; CKD Biomarkers Consortium and the RASS Investigators.

Nephrol Dial Transplant. 2015 Apr;30(4):599-606. doi: 10.1093/ndt/gfv012. Epub 2015 Feb 3.

20.

Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD; Chronic Kidney Disease Biomarkers Consortium Investigators.

Diabetologia. 2015 Jan;58(1):188-98. doi: 10.1007/s00125-014-3389-3. Epub 2014 Oct 15.

21.

Variants associated with type 2 diabetes identified by the transethnic meta-analysis study: assessment in American Indians and evidence for a new signal in LPP.

Nair AK, Muller YL, McLean NA, Abdussamad M, Piaggi P, Kobes S, Weil EJ, Curtis JM, Nelson RG, Knowler WC, Hanson RL, Baier LJ.

Diabetologia. 2014 Nov;57(11):2334-8. doi: 10.1007/s00125-014-3351-4. Epub 2014 Aug 12.

22.

A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes.

Hanson RL, Muller YL, Kobes S, Guo T, Bian L, Ossowski V, Wiedrich K, Sutherland J, Wiedrich C, Mahkee D, Huang K, Abdussamad M, Traurig M, Weil EJ, Nelson RG, Bennett PH, Knowler WC, Bogardus C, Baier LJ.

Diabetes. 2014 Jan;63(1):369-76. doi: 10.2337/db13-0416. Epub 2013 Oct 7.

23.

Response to Comment on: Chakkera et al. Can New-Onset Diabetes After Kidney Transplant Be Prevented? Diabetes Care 2013;36:1406-1412.

Chakkera HA, Pham PT, Pomeroy J, Weil EJ, Knowler WC.

Diabetes Care. 2013 Oct;36(10):e183. doi: 10.2337/dc13-1656. No abstract available.

24.

The relationship between insulin sensitivity and maximal oxygen uptake is confounded by method of adjustment for body composition.

Grice BA, Mason CC, Weil EJ, Knowler WC, Pomeroy J.

Diab Vasc Dis Res. 2013 Nov;10(6):530-5. doi: 10.1177/1479164113501529. Epub 2013 Sep 22.

PMID:
24062163
25.

Validation of a pretransplant risk score for new-onset diabetes after kidney transplantation.

Chakkera HA, Chang YH, Ayub A, Gonwa TA, Weil EJ, Knowler WC.

Diabetes Care. 2013 Oct;36(10):2881-6. doi: 10.2337/dc13-0428. Epub 2013 Sep 5.

26.

Can new-onset diabetes after kidney transplant be prevented?

Chakkera HA, Weil EJ, Pham PT, Pomeroy J, Knowler WC.

Diabetes Care. 2013 May;36(5):1406-12. doi: 10.2337/dc12-2067. Review.

27.

Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes.

Weil EJ, Fufaa G, Jones LI, Lovato T, Lemley KV, Hanson RL, Knowler WC, Bennett PH, Yee B, Myers BD, Nelson RG.

Diabetes. 2013 Sep;62(9):3224-31. doi: 10.2337/db12-1512. Epub 2013 Apr 1. Erratum in: Diabetes. 2018 Jan 5;:.

28.

From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.

Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, Weil EJ, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ, Werner T, Kretzler M.

Diabetes. 2013 Jul;62(7):2605-12. doi: 10.2337/db12-1416. Epub 2013 Feb 22.

29.

Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.

Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, Weil EJ, Cavalcoli JD, Patel JM, Brosius FC 3rd, Kretzler M.

Diabetes. 2013 Jan;62(1):299-308. doi: 10.2337/db11-1667. Epub 2012 Nov 8.

30.

Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.

Weil EJ, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, Lovato T, Richardson M, Myers BD, Nelson RG.

Kidney Int. 2012 Nov;82(9):1010-7. doi: 10.1038/ki.2012.234. Epub 2012 Jun 20.

31.

Pretransplant risk score for new-onset diabetes after kidney transplantation.

Chakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC.

Diabetes Care. 2011 Oct;34(10):2141-5. doi: 10.2337/dc11-0752.

32.

Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2444-51. doi: 10.2215/CJN.00580111. Epub 2011 Aug 18.

33.

Podocyte detachment in type 2 diabetic nephropathy.

Weil EJ, Lemley KV, Yee B, Lovato T, Richardson M, Myers BD, Nelson RG.

Am J Nephrol. 2011;33 Suppl 1:21-4. doi: 10.1159/000327047. Epub 2011 Jun 10.

34.

The impact of disadvantage on the development and progression of diabetic kidney disease.

Weil EJ, Curtis JM, Hanson RL, Knowler WC, Nelson RG.

Clin Nephrol. 2010 Nov;74 Suppl 1:S32-8. Review.

35.

Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus.

Chakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1669-75. doi: 10.2215/CJN.09481209. Epub 2010 Jun 17.

36.

Predictive value of albuminuria in American Indian youth with or without type 2 diabetes.

Kim NH, Pavkov ME, Knowler WC, Hanson RL, Weil EJ, Curtis JM, Bennett PH, Nelson RG.

Pediatrics. 2010 Apr;125(4):e844-51. doi: 10.1542/peds.2009-1230. Epub 2010 Mar 1.

37.

Hyperglycemia during the immediate period after kidney transplantation.

Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB.

Clin J Am Soc Nephrol. 2009 Apr;4(4):853-9. doi: 10.2215/CJN.05471008. Epub 2009 Apr 1.

38.

Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes.

Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, Knowler WC, Nelson RG.

Diabetes Care. 2007 Feb;30(2):306-11.

PMID:
17259499
39.

Kidney disease among the indigenous peoples of Oceania.

Weil EJ, Nelson RG.

Ethn Dis. 2006 Spring;16(2 Suppl 2):S2-24-30.

PMID:
16774006
40.

Impact of lifestyle on prevalence of kidney disease in Pima Indians in Mexico and the United States.

Valencia ME, Weil EJ, Nelson RG, Esparza J, Schulz LO, Ravussin E, Bennett PH.

Kidney Int Suppl. 2005 Aug;(97):S141-4.

41.

Cloning and analysis of the CYP1A promoter from the atlantic killifish (Fundulus heteroclitus).

Powell WH, Morrison HG, Weil EJ, Karchner SI, Sogin ML, Stegeman JJ, Hahn ME.

Mar Environ Res. 2004 Aug-Dec;58(2-5):119-24.

PMID:
15178023
42.

[False aneurysm of the lateral superior genicular artery. A complication after the implantation of a knee prosthesis].

Kirschner S, Konrad T, Weil EJ, Bühler M.

Orthopade. 2004 Jul;33(7):841-5. German.

PMID:
15095036
43.

Molecular cloning of CYP1A from the estuarine fish Fundulus heteroclitus and phylogenetic analysis of CYP1 genes: update with new sequences.

Morrison HG, Weil EJ, Karchner SI, Sogin ML, Stegeman JJ.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Nov;121(1-3):231-40.

PMID:
9972465

Supplemental Content

Support Center